Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Kirchgaessler KU"'
Publikováno v:
Thorax; 2017, Vol. 72 Issue: Supplement 3 pA254-A254, 1p
Publikováno v:
Thorax; 2017, Vol. 72 Issue: Supplement 3 pA251-A251, 1p
Autor:
Wells AU; Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK. RBHILD@rbht.nhs.uk., Jacob J; Department of Respiratory Medicine, University College London, London, UK.; Satsuma Lab, Centre for Medical Image Computing, University College London, London, UK., Sverzellati N; Scienze Radiologiche, Department of Medicine and Surgery, University Hospital Parma, Parma, Italy., Cross G; Royal Free Hospital, London, UK., Barnett J; Royal Free Hospital, London, UK., De Lauretis A; Department of Respiratory Medicine, University of Insubria, Ospedale di Circolo, Varese, Italy., Antoniou K; Interstitial Lung Disease Unit, Department of Thoracic Medicine, School of Medicine, University of Crete, Heraklion, Greece., Weycker D; Policy Analysis Inc. (PAI), Brookline, MA, USA., Atwood M; Policy Analysis Inc. (PAI), Brookline, MA, USA., Kirchgaessler KU; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Cottin V; National Reference Center for Rare Pulmonary Diseases (OrphaLung), Louis Pradel Hospital, Hospices Civils de Lyon, ERN-LUNG, Lyon, France.; Université Claude Bernard Lyon 1, Lyon, France.
Publikováno v:
Respiratory research [Respir Res] 2024 Jan 18; Vol. 25 (1), pp. 33. Date of Electronic Publication: 2024 Jan 18.
Autor:
Maher TM; National Heart and Lung Institute, Imperial College London, London, UK. Toby.Maher@med.usc.edu.; Hastings Center for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Toby.Maher@med.usc.edu., Schiffman C; Genentech, Inc., South San Francisco, CA, USA., Kreuter M; Center for Interstitial and Rare Lung Diseases, Pulmonology, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.; German Center for Lung Research, Heidelberg, Germany., Moor CC; Center for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, 3015 GD, Rotterdam, The Netherlands., Nathan SD; The Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA., Axmann J; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Belloni P; Genentech, Inc., South San Francisco, CA, USA., Bengus M; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Gilberg F; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Kirchgaessler KU; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Wijsenbeek MS; Center for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, 3015 GD, Rotterdam, The Netherlands.
Publikováno v:
Respiratory research [Respir Res] 2022 Nov 11; Vol. 23 (1), pp. 307. Date of Electronic Publication: 2022 Nov 11.
Autor:
Harari S; Dept of Clinical Sciences and Community Health, University of Milan, Milan, Italy.; U.O. di Pneumologia e Terapia Semi-Intensiva Respiratoria, Ospedale San Guiseppe, MultiMedica IRCCS, Milan, Italy., Wells AU; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK., Wuyts WA; Unit for Interstitial Lung Diseases, University of Leuven, Leuven, Belgium., Nathan SD; The Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA., Kirchgaessler KU; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Bengus M; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Behr J; Dept of Medicine V, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany juergen.behr@med.uni-muenchen.de.; Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Munich, Germany.
Publikováno v:
European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2022 Aug 23; Vol. 31 (165). Date of Electronic Publication: 2022 Aug 23 (Print Publication: 2022).
Autor:
Molina-Molina M; ILD Unit, Respiratory Department, University Hospital of Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Madrid, Spain., Kreuter M; Center for Interstitial and Rare Lung Diseases, Dep-Pneumonology, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.; German Center for Lung Research, Heidelberg, Germany., Cottin V; National Reference Coordinating Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Member of ERN-LUNG, Lyon, France.; IVPC, Université Claude Bernard Lyon 1, UMR754, INRAE, Lyon, France., Corte TJ; Department of Respiratory Medicine, Royal Prince Alfred Hospital, University of Sydney, Sydney, NSW, Australia.; Medical School, University of Sydney, Camperdown, NSW, Australia., Gilberg F; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Kirchgaessler KU; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Axmann J; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Maher TM; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom.; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Hastings Center for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2022 Jun 17; Vol. 9, pp. 897102. Date of Electronic Publication: 2022 Jun 17 (Print Publication: 2022).
Autor:
Wuyts WA; Department of Respiratory Medicine, Unit for Interstitial Lung Diseases, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. wim.wuyts@uzleuven.be., Dahlqvist C; CHU UCL Namur Site Godinne, Yvoir, Belgium., Slabbynck H; Department of Respiratory Medicine, ZNA Middelheim, Antwerp, Belgium., Schlesser M; Department of Respiratory Care, Hôpitaux Robert Schuman, Luxembourg City, Luxembourg., Gusbin N; CHR de la Citadelle, Liege, Belgium., Compere C; CHIREC Hospital, Brussels, Belgium., Maddens S; AZ Groeninge, Kortrijk, Belgium., Rizzo S; Genentech, Inc., South San Francisco, CA, USA., Kirchgaessler KU; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Bartley K; Genentech, Inc., South San Francisco, CA, USA., Bondue B; Department of Respiratory Medicine, Erasme University Hospital, Brussels, Belgium.
Publikováno v:
Pulmonary therapy [Pulm Ther] 2022 Jun; Vol. 8 (2), pp. 181-194. Date of Electronic Publication: 2022 Apr 16.
Autor:
Kreuter M; Department of Pulmonology and Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, Roentgen Street 1, 69126, Heidelberg, Germany. kreuter@uni-heidelberg.de.; German Center for Lung Research, Heidelberg, Germany. kreuter@uni-heidelberg.de., Maher TM; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.; Fibrosis Research Group, National Heart and Lung Institute, Imperial College London, London, UK.; Hastings Center for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Corte TJ; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.; Medical School, University of Sydney, Camperdown, NSW, Australia., Molina-Molina M; ILD Unit, Respiratory Department, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), University Hospital of Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Madrid, Spain., Axmann J; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Gilberg F; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Kirchgaessler KU; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Cottin V; National Reference Coordinating Center for Rare Pulmonary Diseases (OrphaLung), Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.; IVPC, INRAE, Member of ERN-LUNG, University of Lyon, Lyon, France.
Publikováno v:
Advances in therapy [Adv Ther] 2022 Feb; Vol. 39 (2), pp. 1081-1095. Date of Electronic Publication: 2021 Dec 22.
Autor:
Jouneau S; Department of Respiratory Diseases, Hôpital Pontchaillou, Univ Rennes, INSERM, EHESP, IRSET UMR_S1085, Rennes, France., Crestani B; Department of Pulmonology, AP-HP, Hôpital Bichat, FHU APOLLO, Inserm 1152, Université de Paris, Paris, France., Thibault R; Unité de Nutrition, CHU Rennes, INRAE, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Rennes, France., Lederlin M; Department of Radiology, Univ Rennes, CHU Rennes, INSERM, LTSI, UMR 1099, Rennes, France., Vernhet L; INSERM, EHESP, IRSET (Institut de recherche en santé, environnement et travail), Univ Rennes, UMR_S1085, Rennes, France., Yang M; Genentech, Inc., South San Francisco, California, USA., Morgenthien E; Genentech, Inc., South San Francisco, California, USA., Kirchgaessler KU; F. Hoffmann-La Roche, Ltd., Basel, Switzerland., Cottin V; National Reference Coordinating Center for Rare Pulmonary Diseases, Louis Pradel Hospital and Hospices Civils de Lyon, Université Claude Bernard Lyon 1, UMR754, member of OrphaLung, RespiFil, ERN-LUNG, Lyon, France.
Publikováno v:
Respiration; international review of thoracic diseases [Respiration] 2022; Vol. 101 (2), pp. 142-154. Date of Electronic Publication: 2021 Oct 05.
Autor:
Kreuter M; Center for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.; German Center for Lung Research, Heidelberg, Germany., Lee JS; Department of Medicine, University of Colorado, Denver, Colorado., Tzouvelekis A; Department of Respiratory Medicine, University of Patras, Patras, Greece., Oldham JM; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of California Davis, Sacramento, California., Molyneaux PL; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom.; Fibrosis Research Group, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Weycker D; Policy Analysis, Inc., Brookline, Massachusetts., Atwood M; Policy Analysis, Inc., Brookline, Massachusetts., Kirchgaessler KU; F. Hoffmann-La Roche, Ltd., Basel, Switzerland; and., Maher TM; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom.; Fibrosis Research Group, National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Hastings Center for Pulmonary Research and Division of Pulmonary, Critical Care, and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Jul 01; Vol. 204 (1), pp. 74-81.